Actavis Totowa in New Jersey extends drug recall

August 1, 2008 -- Actavis Totowa LLC, a generic drug manufacturer, is announcing a voluntary recall, at the retail level, of all drug products manufactured at its Little Falls, New Jersey facility.
This recall to pharmacies and hospitals only follows an inspection by the Food and Drug Administration made earlier this year where facility operations didn't meet the FDA or Actavis' standards.

The voluntary recall is not prompted by product complaints or health hazards associated with the products, which are all prescription medications. Patients who may have these medicines in their possession should continue to take them because stopping suddenly places patients at risk.
Actavis Totowa, LLC is a United States subsidiary of Actavis Group hf. This voluntary action is limited to most but not all the Actavis Totowa products manufactured in the Little Falls, NJ facility. View a complete list of recalled products.

Digitek (Digoxin, which is manufactured by Actavis and is also being recalled because the active ingredient in some tablets were double dosed causing toxicity) is not part of this latest recall but has its own recall.

Please refer to the FAQs for additional information.